Skip to content

Influences of fermented Pu-er tea on the blood biochemical biomarkers and gut microbiota of healthy human

Influences of fermented Pu-er tea on the blood biochemical biomarkers and gut microbiota of healthy human

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOh-17010592
Enrollment
Unknown
Registered
2017-02-09
Start date
2017-02-13
Completion date
Unknown
Last updated
2017-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intesitnal function

Interventions

50mg/kg body weight aqueous extract of fermented Pu-er tea:self drinking

Sponsors

School of Life Sciences, Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1. Healthy young adults aged from 22-35 with good life style living in Changchun city for more than 1 year; 2. All regular check-up indicators of young adults are in the range of normal reference; 3. They did not have the experience of eating fermented Pu-er tea and its relative products.

Exclusion criteria

Exclusion criteria: 1. People have received treatment for diabetes, hypertension, or dyslipidemia, nor did they have any acute or chronic inflammatory diseases, infectious diseases, viral infections, cancer, or had a previous cardiovascular event at study entry. They had received any antibiotic therapy, prebiotics, probiotics or vitamin supplements or any other medical treatment influencing intestinal microbiota during the 3 months before and during the study (2 month before, 1month during the study); 2. Pepole who take antibiotics, catch a cold, fever, diarrhea or other physical discomfort in 3 months before and after the intervention of (1 month before intervention, 2 months during and after intervention); 3. People who have smoking, alcohol drinking, carbonic acid beverage drinking, probiotics and prebiotics supplements administration habits; 4. People who have participated in other clinical trials; 5. Other reasons are not suitable for clinical subjects, according to the researchers.

Design outcomes

Primary

MeasureTime frame
gut microbiota;blood biochemical measurements;Anthropometry parameters;

Countries

China

Contacts

Public ContactHongyu Xiang

School of Life Sciences, Jilin University

hyxiang@jlu.edu.cn+86 13944865511

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026